155 related articles for article (PubMed ID: 33281863)
1. Systematic Analyses of the Differentially Expressed Alternative Splicing Events in Gastric Cancer and Its Clinical Significance.
Lin C; Yu B; Zhang M; Chen Y; Li L; Zhao D
Front Genet; 2020; 11():522831. PubMed ID: 33281863
[TBL] [Abstract][Full Text] [Related]
2. Profiles of alternative splicing in colorectal cancer and their clinical significance: A study based on large-scale sequencing data.
Xiong Y; Deng Y; Wang K; Zhou H; Zheng X; Si L; Fu Z
EBioMedicine; 2018 Oct; 36():183-195. PubMed ID: 30243491
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Analysis of Alternative Splicing Signature in Gastric Cancer Prognosis Based on The Cancer Genome Atlas (TCGA) and SpliceSeq Databases.
Cheng X; Li X; Gu Y; Zhou L; Tang J; Dai X; Jiang H; Huang Y; Zhang Y; Xu T; Liu Z; Zhao Q
Med Sci Monit; 2020 Nov; 26():e925772. PubMed ID: 33219199
[TBL] [Abstract][Full Text] [Related]
4. Profiles of alternative splicing events in the diagnosis and prognosis of Gastric Cancer.
Wei C; Xie W; Huang X; Mo X; Liu Z; Wu G; Meng Y; Jeen F; Ge L; Zhang L; Liao L; Liu J; Tang W
J Cancer; 2021; 12(10):2982-2992. PubMed ID: 33854599
[No Abstract] [Full Text] [Related]
5. The landscape of alternative splicing reveals novel events associated with tumorigenesis and the immune microenvironment in gastric cancer.
Lou S; Zhang J; Zhai Z; Yin X; Wang Y; Fang T; Xue Y
Aging (Albany NY); 2021 Jan; 13(3):4317-4334. PubMed ID: 33428603
[TBL] [Abstract][Full Text] [Related]
6. Profiles of alternative splicing landscape in breast cancer and their clinical significance: an integrative analysis based on large-sequencing data.
Du JX; Liu YL; Zhu GQ; Luo YH; Chen C; Cai CZ; Zhang SJ; Wang B; Cai JL; Zhou J; Fan J; Dai Z; Zhu W
Ann Transl Med; 2021 Jan; 9(1):58. PubMed ID: 33553351
[TBL] [Abstract][Full Text] [Related]
7. Genome-Wide Transcriptional Analysis Reveals Alternative Splicing Event Profiles in Hepatocellular Carcinoma and Their Prognostic Significance.
Xiong Y; Yang G; Wang K; Riaz M; Xu J; Lv Z; Zhou H; Li Q; Li W; Sun J; Tao T; Li J
Front Genet; 2020; 11():879. PubMed ID: 32849842
[TBL] [Abstract][Full Text] [Related]
8. Systematic profiling of alternative splicing signature reveals prognostic predictor for prostate cancer.
Zhao J; Chang L; Gu X; Liu J; Sun B; Wei X
Cancer Sci; 2020 Aug; 111(8):3020-3031. PubMed ID: 32530556
[TBL] [Abstract][Full Text] [Related]
9. Systematic profiling of alternative splicing in
Liu C; Hu C; Li Z; Feng J; Huang J; Yang B; Wen T
Cancer Cell Int; 2020; 20():279. PubMed ID: 32617077
[TBL] [Abstract][Full Text] [Related]
10. Signature of gene aberrant alternative splicing events in pancreatic adenocarcinoma prognosis.
Yao J; Tang YC; Yi B; Yang J; Chai Y; Yin N; Zhang ZX; Wei YJ; Li DC; Zhou J
J Cancer; 2021; 12(11):3164-3179. PubMed ID: 33976726
[TBL] [Abstract][Full Text] [Related]
11. Identification of Prognostic Alternative Splicing Signature in Breast Carcinoma.
Zhang D; Duan Y; Cun J; Yang Q
Front Genet; 2019; 10():278. PubMed ID: 30984247
[TBL] [Abstract][Full Text] [Related]
12. Role of alternative splicing events in endometrial cancer prognosis.
Liu J; Mi C; Long W; Sun T
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Jul; 46(7):680-688. PubMed ID: 34382583
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Signatures of Alternative Splicing Events in Esophageal Carcinoma Based on TCGA Splice-Seq Data.
Ye P; Yang Y; Zhang L; Zheng G
Front Oncol; 2021; 11():658262. PubMed ID: 34676158
[TBL] [Abstract][Full Text] [Related]
14. An alternative splicing signature model for predicting hepatocellular carcinoma-specific survival.
Dong S; Lu LJ
J Gastrointest Oncol; 2020 Oct; 11(5):1054-1064. PubMed ID: 33209497
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases.
He RQ; Zhou XG; Yi QY; Deng CW; Gao JM; Chen G; Wang QY
Cell Physiol Biochem; 2018; 48(3):1355-1368. PubMed ID: 30048970
[TBL] [Abstract][Full Text] [Related]
16. Identification of prognostic alternative splicing signature in gastric cancer.
Wang Z; Wu Q; Liu Y; Li Q; Li J
Arch Public Health; 2022 May; 80(1):145. PubMed ID: 35614517
[TBL] [Abstract][Full Text] [Related]
17. Systematic analysis and prediction model construction of alternative splicing events in hepatocellular carcinoma: a study on the basis of large-scale spliceseq data from The Cancer Genome Atlas.
Yang L; He Y; Zhang Z; Wang W
PeerJ; 2019; 7():e8245. PubMed ID: 31844595
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of an individual alternative splicing prognostic signature in gastric cancer.
Lou S; Zhang J; Zhai Z; Yin X; Wang Y; Fang T; Xue Y
Aging (Albany NY); 2021 Feb; 13(4):5824-5844. PubMed ID: 33612482
[TBL] [Abstract][Full Text] [Related]
19. Identification of Survival-Associated Alternative Splicing Signatures in Lung Squamous Cell Carcinoma.
Liu Y; Jia W; Li J; Zhu H; Yu J
Front Oncol; 2020; 10():587343. PubMed ID: 33117720
[No Abstract] [Full Text] [Related]
20. Systematic profiling of a novel prognostic alternative splicing signature in hepatocellular carcinoma.
Zhang D; Duan Y; Wang Z; Lin J
Oncol Rep; 2019 Dec; 42(6):2450-2472. PubMed ID: 31578577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]